Healthcare innovation and patent law's 'pharmaceutical privilege': is there a pharmaceutical privilege? And if so, should we remove it?
about
Healthcare innovation and patent law's 'pharmaceutical privilege': is there a pharmaceutical privilege? And if so, should we remove it?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Healthcare innovation and pate ...... nd if so, should we remove it?
@en
Healthcare innovation and pate ...... nd if so, should we remove it?
@nl
type
label
Healthcare innovation and pate ...... nd if so, should we remove it?
@en
Healthcare innovation and pate ...... nd if so, should we remove it?
@nl
prefLabel
Healthcare innovation and pate ...... nd if so, should we remove it?
@en
Healthcare innovation and pate ...... nd if so, should we remove it?
@nl
P2860
P1154
2-s2.0-85017516394
P1476
Healthcare innovation and pate ...... nd if so, should we remove it?
@en
P2093
Graham Dutfield
P2860
P304
P356
10.1017/S1744133117000111
P5530
P577
2017-04-18T00:00:00Z
P6179
1084921922